These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2775877

  • 1. Effects of oral administration of artificial cells immobilized phenylalanine ammonia-lyase on intestinal amino acids of phenylketonuric rats.
    Bourget L, Chang TM.
    Biomater Artif Cells Artif Organs; 1989; 17(2):161-81. PubMed ID: 2775877
    [Abstract] [Full Text] [Related]

  • 2. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model.
    Bourget L, Chang TM.
    Biochim Biophys Acta; 1986 Oct 01; 883(3):432-8. PubMed ID: 3756210
    [Abstract] [Full Text] [Related]

  • 3. Phenylalanine ammonia-lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria.
    Bourget L, Chang TM.
    FEBS Lett; 1985 Jan 21; 180(1):5-8. PubMed ID: 4038490
    [Abstract] [Full Text] [Related]

  • 4. A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria.
    Chang TM, Bourget L, Lister C.
    Artif Cells Blood Substit Immobil Biotechnol; 1995 Jan 21; 23(1):1-21. PubMed ID: 7719440
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
    Ambrus CM, Sharma SD, Horváth C, Kalghatgi K, Anthone S, Ambrus JL, Cooley C, Mirand EA.
    J Pharmacol Exp Ther; 1983 Mar 21; 224(3):598-602. PubMed ID: 6681841
    [Abstract] [Full Text] [Related]

  • 9. Enzymatic control of phenylalanine intake in phenylketonuria.
    Hoskins JA, Jack G, Wade HE, Peiris RJ, Wright EC, Starr DJ, Stern J.
    Lancet; 1980 Feb 23; 1(8165):392-4. PubMed ID: 6101846
    [Abstract] [Full Text] [Related]

  • 10. Depletion of phenylalanine in the blood of phenylketonuric patients using a PAL-enzyme reactor. An in vitro study.
    Ambrus CM, Horváth C, Kalghatgi K, Clowsley M, Huzella C, Warner R, Ambrus JL, Cooley CM, Mirand EA.
    Res Commun Chem Pathol Pharmacol; 1982 Jul 23; 37(1):105-11. PubMed ID: 7122995
    [Abstract] [Full Text] [Related]

  • 11. An extracorporeal hollow-fiber reactor for phenylketonuria using immobilized phenylalanine ammonia lyase.
    Larue C, Munnich A, Charpentier C, Saudubray JM, Frézal J, Rémy MH, Rivat C.
    Dev Pharmacol Ther; 1986 Jul 23; 9(2):73-81. PubMed ID: 3956347
    [Abstract] [Full Text] [Related]

  • 12. [Study of blood amino acids during a phenylalanine loading test].
    Dhondt JL, Farriaux JP.
    Biomedicine; 1975 Apr 30; 23(4):149-54. PubMed ID: 1222234
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.
    Sarkissian CN, Kang TS, Gámez A, Scriver CR, Stevens RC.
    Mol Genet Metab; 2011 Nov 30; 104(3):249-54. PubMed ID: 21803624
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuria.
    Ambrus CM, Anthone S, Horvath C, Kalghatgi K, Lele AS, Eapen G, Ambrus JL, Ryan AJ, Li P.
    Ann Intern Med; 1987 Apr 30; 106(4):531-7. PubMed ID: 3826953
    [Abstract] [Full Text] [Related]

  • 20. Of mice and men: Plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain.
    Berguig GY, Martin NT, Creer AY, Xie L, Zhang L, Murphy R, Pacheco G, Bullens S, Olbertz J, Weng HH.
    Mol Genet Metab; 2019 Dec 30; 128(4):422-430. PubMed ID: 31648944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.